In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(ε-caprolactone) microparticles

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 7, 2005, Pages 3025-3027

  Le Ray, Anne Marie ^a   Gautier, Hélène ^a   Laty, Marie Katel ^a   Daculsi, Guy ^a   Merle, Christian ^a   Jacqueline, Cédric ^a   Hamel, Antoine ^a   Caillon, Jocelyne ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; POLYCAPROLACTONE; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BIODEGRADABILITY; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG FORMULATION; DRUG IMPLANTATION; ENCAPSULATION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; COLONY COUNT, MICROBIAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HEXANOIC ACIDS; LACTONES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 21444459869     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.7.3025-3027.2005     Document Type: Article

References (33)

1. Argenson, J. N. 1993. Etude de l'association vancomycine-tobramycine et ciment orthopédique (diffusion, propriétés mécaniques, efficacité). Ph.D thesis. UFR de Medecine, University of Marseille, Marseille, France.
2. Benoit, M. A., B. Mousset, C. Delloye, R. Bouillet, and J. Gillard. 1997. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections. Int. Orthop. 21:403-408.
3. Del Nozal, M. J., J. L. Bernal, A. Pampliega, P. Marinere, M. L. Lopez, and R. Coco. 1996. High-performance liquid chromatographic determination of vancomycin in rabbit serum, vitreous and aqueous humour after intravitreal injection of the drug. J. Chromatogr. 727:231-238.
4. Dupraz, A., T. P. Nguyen, M. Richard, J. Delecrin, and G. Daculsi. 1996. Microcharacterization of a new injectable polymer/ceramic composite as bone substitute in spine surgery. J. Mater. Sci. Mater. Med. 7:52-55.
5. El Kouri, D., F. Le Gallou, A. Kenzi, D. Trewick, D. Baron, and G. Potel. 1998. Thérapeutique des infections à staphylocoques. Encycl. Med. Chir. 10:1-7.
6. Engelberg, I., and J. Kohn. 1991. Physico-mechanical properties of degradable polymers using in medical applications: a comparative study. Biomaterials 12:292-304.
7. Gautier, H., J. Caillon, A. M. Le Ray, G. Daculsi, and C. Merle. 2000. Influence of isostatic compression on the stability of vancomycin loaded with a calcium phosphate-implantable drug delivery device. J. Biomed. Mater. Res. 52:308-314.
8. Gautier, H., G. Daculsi, and C. Merle. 2001. Association of vancomycin and calcium phosphate by dynamic compaction: in vitro characterization and microbiological activity. Biomaterials 22:2481-2487.
9. Gautier, H., C. Merle, J. L. Auget, and G. Daculsi. 2000. Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: comparison with a classical method. Biomaterials 21:243-249.
10. Guicheux, J., G. Grimandi, M. Trécant, A. Faivre, S. Takahashi, and G. Daculsi. 1997. Apatite as carrier for growth hormone: in vitro characterization of loading and release. J. Biomed. Mater. Res. 34:165-170.
11. Guzman, M., J. Molpeceres, F. Garcia, and M. R. Aberturas. 1996. Preparation, characterization and in vitro drug release of poly-ε- caprolactone and hydroxypropylmethylcellulose phtalate ketoprophen loaded microspheres. J. Microencapsulation 13:25-39.
12. Hamanishi, C., K. Kitamoto, S. Tanaka, M. Otsuka, Y. Doi, and T. Kitahashi. 1996. A self-setting TTCP-DCPD apatite cement for release of vancomycin. J. Biomed. Mater. Res. 33:139-143.
13. Hutmacher, D. 1996. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int. J. Oral Maxillofac. Implants 11:667-678.
14. Iooss, P., A. M. Le Ray, G. Grimandi, G. Daculsi, and C. Merle. 2001. A new injectable bone substitute combining poly(ε-caprolactone) microparticles with biphasic calcium phosphate granules. Biomaterials 22:2785-2794.
15. Jameela S. R., N. Suma, and A. Jayakrishnan. 1997. Protein release from poly(ε-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J. Biomater. Sci. 8:457-466.
16. Jarcho, M. 1981. Calcium phosphate ceramics as hard tissue prosthetics. Clin. Orthop. Relat. Res. 157:259-278.
17. Le Ray, A. M., S. Chiffoleau, P. Iooss, G. Grimandi, A. Gouyette, G. Daculsi, and C. Merle. 2003. Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility. Biomaterials 24:443-449.
18. Liu, S. J., S. Wen-Neng Ueng, S. S. Lin, and E. C. Chan. 2002. In vivo release of vancomycin from biodegradable beads. J. Biomed. Mater. Res. 63:807-813.
19. Lorian, V. 1991. Laboratory methods used to assess the activity of antimicrobial combinations, p. 434-444. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams and Wilkins Co., Baltimore, Md.
20. Lowry, K. J., K. R. Hamson, L. Bear, Y. B. Peng, R. Calaluce, M. L. Evans, J. O. Anglen, and W. C. Allen. 1997. Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model. J. Biomed. Mater. Res. 36:536-541.
21. Menei, P., A. Croué, V. Daniel, A. Pouplard-Barthelaix, and J. P. Benoît. 1994. Fate and biocompatibility of three types of microspheres implanted into the brain. J. Biomed. Mater. Res. 28:1079-1085.
22. Nicas T. L., and R. D. G. Cooper. 1997. Vancomycin and other glycopeptides, p. 363-392. In: W. R. Strohl (ed.), Biotechnology of antibiotics, 2nd ed. Marcel Dekker Inc., New York, N.Y.
23. Norden, C. W. 1970. Experimental osteomyelitis I: a description of the model. J. Infect. Dis. 122:410-418.
24. Pitt, C. G., F. I. Chasalow, Y. M. Hibionada, D. M. Klimas, and A. Schindler. 1981. Aliphatic polyesters. I. The degradation of poly(ε-caprolactone) in vivo. J. Appl. Polym. Sci. 26:3779-3787.
25. Pitt, C. G., M. M. Gratzl, G. L. Kimmel, J. Surles, and A. Schindler. 1981. Aliphatic polyesters. II. The degradation of poly (DL-lactide), poly(ε-caprolactone), and their copolymers in vivo. Biomaterials 2:215-220.
26. Saito, T., R. Takeuchi, K. Hirakawa, N. Nagata, T. Yoshida, T. Koshino, K. Okuda, M. Takema, and T. Hori. 2002. Slow-releasing potential of vancomycin-loaded porous hydroxyapatite blocks implanted into MRSA osteomyelitis. J. Biomed. Mater. Res. 63:245-251.
27. Scott, D. M., J. C. Rotschafer, and F. Behrens. 1988. Use of vancomycin and tobramycin polymethylmethacrylate impregnated beads in the management of chronic osteomyelitis. Drug Intell. Clin. Pharm. 22:480-483.
28. Shirtliff, M. E., J. H. Calhoun, and J. T. Mader. 2002. Experimental osteomyelitis treatment with antibiotic impregnated hydroxyapatite. Clin. Orthop. 401:239-247.
29. Thies, C. 1981. Biodegradable polymers for parenteral administration. Int. J. Pharm. Technol. Prod. 2:25-32.
30. Thomazeau, H., and F. Langlais. 1996. Relargage d'antibiotiques par implantation osseuse de phosphate tricalcique: Pharmacocinétique in vitro et in vivo de formes galéniques différentes. Chirurgie 121:663-666.
31. Weiss, P., O. Gauthier, J. M. Bouler, G. Grimandi, and G. Daculsi. 1999. Injectable bone substitute using a hydrophilic polymer. Bone 25(Suppl. 2):67S-70S.
32. Venice, I., S. Calis, B. Atilla, H. S. Kas, M. Ozalp, M. Ekizoglu, H. Ilgili, and A. A. Hincal. 2003. In vitro and in vivo evaluation of the efficiency of teicoplanin-loaded biodegradable microparticles formulated for implantation to infected bone defects. J. Microencapsul. 20:705-717.
33. Youan, B. B. C., M. A. Benoit, B. Baras, G. Riveau, and J. Gillard. 1997. Poly(ε-caprolactone) microparticles containing muramyl dipeptide for oral controlled release of adjuvant. J. Control. Release 48:339.